人工智能深度神经网络在体表12导联心电图中识别心电图隐匿型长QT综合征的应用
该诊断性病例对照研究纳入2059例患者,使用多层卷积神经网络分析10秒12导联心电图(AI-ECG)以区分长QT综合征(LQTS)与QTc正常者。AI-ECG区分LQTS的AUC为0.900,优于单独QTc的0.824;在静息QTc正常(<450毫秒)亚组中,AI-ECG的AUC为0.863,而QTc单独为0.741。AI-ECG还能以较高AUC区分LQT1、LQT2和LQT3基因亚型。
要点
- AI-ECG区分LQTS与无LQTS者的AUC为0.900,优于单独QTc的0.824。
- 在静息QTc正常(<450毫秒)患者中,AI-ECG的AUC达0.863,单独QTc仅0.741。
- AI-ECG可区分LQT1、LQT2、LQT3基因亚型,AUC分别为0.921、0.944、0.863。
核心结论
- AI-ECG能区分心电图隐匿型LQTS与因怀疑LQTS就诊但排除诊断的患者,并对LQTS基因型状态提供接近80%准确的遗传检测前预判。
研究设计与样本
- 诊断性病例对照研究,纳入1999年1月1日至2018年12月31日就诊于专门遗传性心律失常门诊的2059例患者。
- 纳入标准为具有1、2或3型LQTS的明确临床和/或基因诊断,或因初始怀疑LQTS就诊但出院时未获该诊断。
- 使用多层卷积神经网络基于10秒12导联心电图(AI-ECG)进行分类,60%患者用于训练、10%用于验证、30%用于测试。
- 共967例LQTS患者和1092例排除LQTS者的全部12导联心电图纳入AI-ECG分析。
主要发现
- 基于心电图推导的QTc单独区分LQTS的AUC为0.824(95%CI 0.79-0.858),AI-ECG的AUC为0.900(95%CI 0.876-0.925)。
- 在静息QTc正常(<450毫秒)亚组中,QTc单独区分LQTS的AUC为0.741(95%CI 0.689-0.794),AI-ECG提高至0.863(95%CI 0.824-0.903)。
- AI-ECG区分LQT1与LQT2/3的AUC为0.921(95%CI 0.890-0.951),区分LQT2与LQT1/3的AUC为0.944(95%CI 0.918-0.970),区分LQT3与LQT1/2的AUC为0.863(95%CI 0.792-0.934)。
临床怎么用
- AI-ECG模型可能有助于在心律失常门诊就诊者中检测LQTS,尤其是静息QTc正常但基因确诊的隐匿型患者。
- 经外部验证后,该模型可能成为在一般人群中开发类似工具的起点。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Long QT syndrome (LQTS) is characterized by prolongation of the QT interval and is associated with an increased risk of sudden cardiac death. However, although QT interval prolongation is the hallmark feature of LQTS, approximately 40% of patients with genetically confirmed LQTS have a normal corrected QT (QTc) at rest. Distinguishing patients with LQTS from those with a normal QTc is important to correctly diagnose disease, implement simple LQTS preventive measures, and initiate prophylactic therapy if necessary. OBJECTIVE: To determine whether artificial intelligence (AI) using deep neural networks is better than the QTc alone in distinguishing patients with concealed LQTS from those with a normal QTc using a 12-lead electrocardiogram (ECG). DESIGN, SETTING, AND PARTICIPANTS: A diagnostic case-control study was performed using all available 12-lead ECGs from 2059 patients presenting to a specialized genetic heart rhythm clinic. Patients were included if they had a definitive clinical and/or genetic diagnosis of type 1, 2, or 3 LQTS (LQT1, 2, or 3) or were seen because of an initial suspicion for LQTS but were discharged without this diagnosis. A multilayer convolutional neural network was used to classify patients based on a 10-second, 12-lead ECG, AI-enhanced ECG (AI-ECG). The convolutional neural network was trained using 60% of the patients, validated in 10% of the patients, and tested on the remaining patients (30%). The study was conducted from January 1, 1999, to December 31, 2018. MAIN OUTCOMES AND MEASURES: The goal of the study was to test the ability of the convolutional neural network to distinguish patients with LQTS from those who were evaluated for LQTS but discharged without this diagnosis, especially among patients with genetically confirmed LQTS but a normal QTc value at rest (referred to as genotype positive/phenotype negative LQTS, normal QT interval LQTS, or concealed LQTS). RESULTS: Of the 2059 patients included, 1180 were men (57%); mean (SD) age at first ECG was 21.6 (15.6) years. All 12-lead ECGs from 967 patients with LQTS and 1092 who were evaluated for LQTS but discharged without this diagnosis were included for AI-ECG analysis. Based on the ECG-derived QTc alone, patients were classified with an area under the curve (AUC) value of 0.824 (95% CI, 0.79-0.858); using AI-ECG, the AUC was 0.900 (95% CI, 0.876-0.925). Furthermore, in the subset of patients who had a normal resting QTc (<450 milliseconds), the QTc alone distinguished those with LQTS from those without LQTS with an AUC of 0.741 (95% CI, 0.689-0.794), whereas the AI-ECG increased this discrimination to an AUC of 0.863 (95% CI, 0.824-0.903). In addition, the AI-ECG was able to distinguish the 3 main genotypic subgroups (LQT1, LQT2, and LQT3) with an AUC of 0.921 (95% CI, 0.890-0.951) for LQT1 compared with LQT2 and 3, 0.944 (95% CI, 0.918-0.970) for LQT2 compared with LQT1 and 3, and 0.863 (95% CI, 0.792-0.934) for LQT3 compared with LQT1 and 2. CONCLUSIONS AND RELEVANCE: In this study, the AI-ECG was found to distinguish patients with electrocardiographically concealed LQTS from those discharged without a diagnosis of LQTS and provide a nearly 80% accurate pregenetic test anticipation of LQTS genotype status. This model may aid in the detection of LQTS in patients presenting to an arrhythmia clinic and, with validation, may be the stepping stone to similar tools to be developed for use in the general population.
引用
- Bos JM, Attia ZI, Albert DE, et al. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram. JAMA Cardiol. 2021. PMID: 33566059. doi:10.1001/jamacardio.2020.7422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。